Faculty who have authored publication A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis.
Name | Title | Department | Institution |
---|---|---|---|
Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |